Nealmongkol, P.; Tangdenpaisal, K.; Ruchirawat, S.; Thasana, N. Cu(I)-mediated Lactone Formation in Subcritical Water: A Benign Synthesis of Benzopyranones and Urolithins A-C. Tetrahedron 2013, 69, 9277–9283.

28 Dec 2013
0
0

Nealmongkol, P.; Tangdenpaisal, K.; Ruchirawat, S.; Thasana, N. Cu(I)-mediated Lactone Formation in Subcritical Water: A Benign Synthesis of Benzopyranones and Urolithins A-C. Tetrahedron 2013, 69, 9277–9283.

Tags

Share this

Related Posts

Hb Siam [alpha15(A13)Gly– data-lazy-src=
01 Feb 2002
0

Hb Siam [alpha15(A13)Gly–>Arg (alpha1) (GGT–>CGT)] is a typical alpha chain hemoglobinopathy without an alpha-thalassemic effect. Turbpaiboon C, Svasti S, Sawangareetakul P, Winichagoon P, Srisomsap C, Siritanaratkul N, Fucharoen S, Wilairat P*, Svasti J. Hemoglobin. 2002 Feb;26(1):77-81.

Hb Siam [alpha15(A13)Gly–>Arg (alpha1) (GGT–>CGT)] is a typical alpha chain hemoglobinopathy without an alpha-thalassemic effect. Turbpaiboon C, Svasti S, Sawangareetakul P, Winichagoon P, Srisomsap C, Siritanaratkul N, Fucharoen S, Wilairat P*, Svasti J. Hemoglobin. 2002 Feb;26(1):77-81.
View More
Chuysinuan, P.; Chunshom, N.; Kotcharat, P.; Thanyacharoen, T.; Techasakul, S.; Ummartyotin, S. The Encapsulation of Green Tea Extract in Cyclodextrin and Loading into Chitosan-Based Composites: Controlled-Release Behavior and Antioxidant Properties. J. Polym. Environ. 2021, 29, 2628–2638
30 Jan 2021
0

Chuysinuan, P.; Chunshom, N.; Kotcharat, P.; Thanyacharoen, T.; Techasakul, S.; Ummartyotin, S. The Encapsulation of Green Tea Extract in Cyclodextrin and Loading into Chitosan-Based Composites: Controlled-Release Behavior and Antioxidant Properties. J. Polym. Environ. 2021, 29, 2628–2638

Chuysinuan, P.; Chunshom, N.; Kotcharat, P.; Thanyacharoen, T.; Techasakul, S.; Ummartyotin, S. The Encapsulation of Green Tea Extract in Cyclodextrin and Loading into Chitosan-Based Composites: Controlled-Release Behavior and Antioxidant Properties. J. Polym. Environ. 2021, 29, 2628–2638
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More